Close
Nordic 9Nordic 9

Meiji Seika Pharma (investor - Corporate Investor)

Japan
See something wrong or missing? Let us know
Offices:Tokyo
Average round investment:10.41M USD
Average number per year:1.0
Distribution: 2025 (1)
Portfolio companies: France Osivax
Mostly invests in: France France (1) Health services (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Meiji Seika Pharma

Name Criteria
United Kingdom Beast Ventures
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Morocco EmergingTech Ventures
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Canada Dominique Ferst
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Netherlands Salamander Investment Network
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom David Prior
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France MGEN
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Italy HTH - Health Technology Holding.
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Switzerland Debiopharm Innovation Fund
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States K5 Global
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
France Bertrand Jelensperger
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.9
  • Active last 12 months: Yes
Top